Lombard Odier Asset Management (Switzerland)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
Lombard Odier Asset Management (Switzerland)'s NVAX Position: Q1 2022 in Review
Lombard Odier Asset Management (Switzerland) sold out of Novavax (NVAX) in Q1 2022, closing a stake of 38,881 shares — an estimated $5.56M sold.
Lombard Odier Asset Management (Switzerland) first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $23.2M in Q2 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.
- Lombard Odier Asset Management (Switzerland) reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
- Lombard Odier Asset Management (Switzerland) sold 38,881 Novavax shares in Q1 2022, an estimated $5.56M.
- Lombard Odier Asset Management (Switzerland) first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
- Lombard Odier Asset Management (Switzerland)'s Novavax position peaked at $23.2M in Q2 2021.
- 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.